89bio Appoints Francis Sarena as Chief Operating Officer by Seini Moimoi | Aug 7, 2024 | Portfolio News
BioAge Announces First Patient Dosed in the STRIDES Phase 2 Clinical Trial Evaluating Azelaprag as a Novel Treatment for Obesity in Combination with Tirzepatide by Seini Moimoi | Jul 29, 2024 | Portfolio News
Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED) by Seini Moimoi | Jul 25, 2024 | Portfolio News
Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older by Seini Moimoi | Jul 25, 2024 | Portfolio News
Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function by Seini Moimoi | Jul 25, 2024 | Portfolio News
Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round by Seini Moimoi | Jul 24, 2024 | Portfolio News
